Lincoln Pharmaceuticals P/B Ratio

Current P/B Ratio
1.68
Moderate Valuation
Moderate - Reasonably valued relative to book value

Lincoln Pharmaceuticals (LINCOLN) P/B ratio is 1.68 (Moderate), book value per share ₹379.00 vs Healthcare average P/B of -0.01 — Moderate - Reasonably valued relative to book value. Explore LINCOLN fundamental worth to estimate fundamental worth using multiple valuation models.

Current Valuation Metrics

P/B Ratio 1.68
Current Price ₹604.85
Book Value/Share ₹379.00
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹758 Cr
Share Capital ₹20 Cr
Reserves & Surplus ₹738 Cr
Outstanding Shares 20,000,000
Book Value per Share ₹379.00

Valuation Signal

Signal Fairly Valued
Historical Avg 1.95
Historical Range 1.44 - 2.66
Percentile 60.0%

Sector Context

Sector Average -0.01
Sector Median 0.62
Sector Rank #11 of 50
Sector Percentile 22.0%

LINCOLN P/B Ratio — Valuation Insights & Book Value Analysis

Lincoln Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 1.68 (Moderate). Read LINCOLN ex-dividend dates for the complete payout history and dividend yield track record.

  • Trading at premium to sector average PB of -0.01

Lincoln Pharmaceuticals P/B Ratio Historical Trend

LINCOLN annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Lincoln Pharmaceuticals screener.

LINCOLN Historical P/B Ratio — Book Value Per Share & Year-End Price

Lincoln Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 1.6 ₹379.0 ₹604.85 ₹758 Moderate
2025 1.44 ₹336.0 ₹483.95 ₹672 Moderate
2024 2.66 ₹296.5 ₹787.80 ₹593 Moderate
2023 2.42 ₹251.5 ₹609.50 ₹503 Moderate
2022 1.64 ₹216.5 ₹355.55 ₹433 Moderate

LINCOLN vs Healthcare Peers — P/B Ratio Comparison

Lincoln Pharmaceuticals P/B 1.68 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.

Sector Average
-0.01
Sector Median
0.62
Lowest P/B
-6.55
Highest P/B
1.09
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.0 ₹65 Low
Krebs Biochemicals & Ind… KREBSBIO -0.82 ₹129 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.21 ₹50 Low
Triochem Products TRIPR 0.04 ₹0 Low